Saleha Anwar
Jamia Hamdard(IN)Jamia Millia Islamia(IN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases, Alzheimer's disease research and treatments, Climate Change and Health Impacts, Synthesis and biological activity
Most-Cited Works
- → Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021(2024)3,952 cited
- → Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy(2020)175 cited
- → Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy(2021)162 cited
- → Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition(2020)158 cited
- → Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021(2024)117 cited
- → Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021(2024)112 cited
- → Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy(2019)109 cited
- → MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy(2020)108 cited
- → Potential drug targets of SARS-CoV-2: From genomics to therapeutics(2021)107 cited
- → Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy(2020)99 cited